EXCITATORY AMINO ACIDS AND SECOND MESSENGER SYSTEMS: With 62 Figures(Ernst Schering Foundation, Workshop 3)

Teichberg, V.I.; Turski, L. (Editors)

ISBN 10: 3540548599 / ISBN 13: 9783540548591

Published by Springer-Verlag, Berlin, Germany, 1991

About this Item

HARD COVER. Text/BRAND NEW & Bright. Black cloth boards/Fine. DJ/None (as Issued?). PO name to first title page. Schering Foundation Workshop 3, June 27-28, 1911, Berlin symposium. Mechanisms through which glutamate, the principal excitatory neurotransmitter in the mammalian central nervous system, modifies neuronal membrane functions and intraneuronal functions. 186 pgs. 12 chapters. Essays review conceptual approaches and experiments reference to links between excitation mediated by glutamate and second messenger systems.

Seller Inventory # 017366

Bibliographic Details

• Title: EXCITATORY AMINO ACIDS AND SECOND MESSENGER SYSTEMS: With 62 Figures(Ernst Schering Foundation, Workshop 3)
• Publisher: Springer-Verlag, Berlin, Germany
• Publication Date: 1991
• Language: English
• ISBN 10: 3540548599
• ISBN 13: 9783540548591
• Binding: Hardcover
• Condition: Near Fine
• Dust Jacket Condition: None (As Issued?)
• Seller catalogs:
  • Biology/Physiology/Botany/Zoology
  • Symposium/Proceedings/Conference
  • Medicine/Medical

About this title

Synopsis

The renewal of interest in excitatory amino acids in the 1980s has altered the direction of neurobiology. L-Glutamate, widely regarded as a general perpetu- ator of nonspecific excitation, has become generally regarded as a widely dis- tributed and important neurotransmitter in the CNS. In the past three decades evidence has accumulated that excitatory amino acids are involved in many neurological diseases and that pharmacological intervention may offer pros- pects of novel and more effective therapies. Numerous studies on experimen- tal animals demonstrate that excitatory amino acid antagonists have anxio- lytic, antiepileptic and muscle relaxant effects. Particular interest has developed in the possible neuroprotective efficacy of excitatory amino acid receptor antagonists in neurological diseases such as hypoxia/ischemia, hypo- glycemia, epilepsy, and chronic neurodegenerative disorders (Huntington's, Alzheimer's, and Parkinson's disease, amyotrophic lateral sclerosis, and AIDS). Thus, the drugs changing neurotransmission mediated by excitatory amino acids possess potential therapeutic value. This volume is part of the Schering Research Foundation Workshop Series. It is the goal of the Schering Research Foundation to promote the asso- ciation between industrial and basic research. The support and the organiza- tion of highly qualified symposia belong to the armamentarium by which this purpose is fulfilled, and we are convinced that the workshop "Excitatory Amino Acids and Second Messenger Systems" has contributed to this. Gunter Stock Ursula-F.